NCT06824467
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06824467
Title A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Sarasota Memorial Hospital ( Site 0075) RECRUITING Sarasota Florida 34239 United States Details
St. Dominic's Hospital ( Site 0064) ACTIVE_NOT_RECRUITING Jackson Mississippi 39216 United States Details
Nebraska Methodist Hospital ( Site 0053) RECRUITING Omaha Nebraska 68114 United States Details
Rutgers Cancer Institute of New Jersey ( Site 0071) RECRUITING New Brunswick New Jersey 08901 United States Details
University of Cincinnati Medical Center ( Site 0090) RECRUITING Cincinnati Ohio 45219 United States Details
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0056) RECRUITING Tulsa Oklahoma 74146 United States Details
Women & Infants Hospital ( Site 0050) RECRUITING Providence Rhode Island 02905 United States Details
Blacktown Hospital ( Site 0211) RECRUITING Sydney New South Wales 2148 Australia Details
Gallipoli Medical Research Ltd ( Site 0214) RECRUITING Brisbane Queensland 4120 Australia Details
Epworth Freemasons ( Site 0217) RECRUITING East Melbourne Victoria 3002 Australia Details
Frankston Hospital ( Site 0216) RECRUITING Frankston Victoria 3199 Australia Details
Kurume University Hospital ( Site 1640) RECRUITING Kurume Fukuoka 830-0011 Japan Details
Saitama Medical University International Medical Center ( Site 1632) RECRUITING Hidaka Saitama 350-1298 Japan Details
Cancer Institute Hospital of JFCR ( Site 1639) RECRUITING Koto Tokyo 135-8550 Japan Details
Keio University Hospital ( Site 1636) RECRUITING Shinjyuku Tokyo 160-8582 Japan Details
Niigata Cancer Center Hospital ( Site 1633) RECRUITING Niigata 951-8566 Japan Details
National Cancer Center ( Site 2305) RECRUITING Goyang-si Kyonggi-do 10408 South Korea Details
Severance Hospital ( Site 2302) RECRUITING Seodaemun-Gu Seoul 03722 South Korea Details
Asan Medical Center ( Site 2304) RECRUITING Songpa-gu Seoul 05505 South Korea Details
Seoul National University Hospital ( Site 2301) RECRUITING Seoul 03080 South Korea Details
Samsung Medical Center ( Site 2303) RECRUITING Seoul 06351 South Korea Details
Institut Català d'Oncologia (ICO) - Girona ( Site 2402) RECRUITING Girona Gerona 17007 Spain Details
Clinica Universidad de Navarra ( Site 2407) RECRUITING Madrid Madrid, Comunidad de 28027 Spain Details
Hospital Vall D Hebron ( Site 2403) RECRUITING Barcelona 08035 Spain Details
ICO L Hospitalet ( Site 2408) RECRUITING Barcelona 08907 Spain Details
Hospital Universitario Reina Sofia ( Site 2406) RECRUITING Córdoba 14004 Spain Details
Hospital Ramon y Cajal ( Site 2405) RECRUITING Madrid 28034 Spain Details
Taichung Veterans General Hospital ( Site 2603) RECRUITING Taichung 40705 Taiwan Details
National Cheng Kung University Hospital ( Site 2602) RECRUITING Tainan 704 Taiwan Details
Mackay Memorial Hospital ( Site 2604) RECRUITING Taipei 104 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field